4/A//SEC Filing
PURA VIDA INVESTMENTS, LLC 4/A
Accession 0001209191-23-024720
CIK 0001642380other
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 6:49 PM ET
Size
17.6 KB
Accession
0001209191-23-024720
Insider Transaction Report
Form 4/AAmended
Kamen Efrem
10% Owner
Transactions
- Other
Warrant to purchase common stock
2023-03-06−440,964→ 517,245 total(indirect: By the Managed Accounts.)Exercise: $1.53From: 2022-04-19Exp: 2027-04-19→ Common Stock (440,964 underlying) - Other
Common Stock
2023-03-06−3,890,111→ 4,589,571 total(indirect: By the Managed Accounts.)
Holdings
- 767,952(indirect: By Pura Vida X Fund LP)
Common Stock
- 7,427,202(indirect: By Pura Vida Master Fund, Ltd.)
Common Stock
- 383,976(indirect: By Pura Vida X Fund LP)
Warrant to purchase common stock
Exercise: $1.53From: 2022-04-19Exp: 2027-04-19→ Common Stock (383,976 underlying) - 690,719(indirect: By Trust)
Warrant to purchase common stock
Exercise: $1.53From: 2022-04-19Exp: 2027-04-19→ Common Stock (690,719 underlying) - 1,381,438(indirect: By Trust)
Common Stock
- 832,949(indirect: By Pura Vida Master Fund, Ltd.)
Warrant to purchase common stock
Exercise: $1.53From: 2022-04-19Exp: 2027-04-19→ Common Stock (832,949 underlying)
PURA VIDA INVESTMENTS, LLC
10% Owner
Transactions
- Other
Common Stock
2023-03-06−3,890,111→ 4,589,571 total(indirect: By the Managed Accounts.) - Other
Warrant to purchase common stock
2023-03-06−440,964→ 517,245 total(indirect: By the Managed Accounts.)Exercise: $1.53From: 2022-04-19Exp: 2027-04-19→ Common Stock (440,964 underlying)
Holdings
- 767,952(indirect: By Pura Vida X Fund LP)
Common Stock
- 7,427,202(indirect: By Pura Vida Master Fund, Ltd.)
Common Stock
- 383,976(indirect: By Pura Vida X Fund LP)
Warrant to purchase common stock
Exercise: $1.53From: 2022-04-19Exp: 2027-04-19→ Common Stock (383,976 underlying) - 1,381,438(indirect: By Trust)
Common Stock
- 832,949(indirect: By Pura Vida Master Fund, Ltd.)
Warrant to purchase common stock
Exercise: $1.53From: 2022-04-19Exp: 2027-04-19→ Common Stock (832,949 underlying) - 690,719(indirect: By Trust)
Warrant to purchase common stock
Exercise: $1.53From: 2022-04-19Exp: 2027-04-19→ Common Stock (690,719 underlying)
Footnotes (6)
- [F1]As of March 6, 2023, the Reporting Persons no longer have voting and dispositive power for certain Managed Accounts and therefore such shares are no longer deemed beneficially owned by the Reporting Persons.
- [F2]Not applicable.
- [F3]Securities reported herein are owned by Pura Vida Master Fund, Ltd., Pura Vida X Fund LP, and Lockheed Martin Corporation Master Retirement Trust (the "Retirement Trust") and certain separately managed accounts (the "Managed Accounts" and collectively, the "Client Accounts"). Pura Vida Investments, LLC ("PVI") serves as the investment manager or sub-adviser to the Client Accounts. Efrem Kamen serves as the Managing Member of PVI.
- [F4]By virtue of these relationships, the Reporting Persons may be deemed to have shared voting and dispositive power with respect to the securities owned directly by the Client Accounts. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein, if any.
- [F5]As of March 6, 2023, the Reporting Persons no longer have voting and dispositive power for certain Managed Accounts and therefore the warrants and the underlying common stock are no longer deemed beneficially owned by the Reporting Persons.
- [F6]See footnotes 3 and 4.
Documents
Issuer
Oncocyte Corp
CIK 0001642380
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001590144
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 17, 8:00 PM ET
- Accepted
- Apr 18, 6:49 PM ET
- Size
- 17.6 KB